Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling relative survival using transformation methods.

Dionne L Price1, Amita K Manatunga

  • 1U.S. Food and Drug Administration, Division of Biometric II. 5600 Fishers Lane, HFD-715, Rockville, Maryland 20857, USA.

Statistics in Medicine
|July 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model-based clustering of multiple images incorporating covariates.

Statistical methods in medical research·2026
Same author

Incidence of hidradenitis suppurativa in transgender and cisgender individuals: A multicenter matched cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Acne Incidence and Severity in Transgender Individuals.

JAMA dermatology·2026
Same author

Assessing intra- and inter-method agreement of functional data.

Statistical methods in medical research·2023
Same author

An integrative latent class model of heterogeneous data modalities for diagnosing kidney obstruction.

Biostatistics (Oxford, England)·2023
Same author

Special issue dedicated to David Oakes.

Lifetime data analysis·2022

This study introduces a new statistical model to analyze patient survival in cancer trials, finding the multiplicative model better describes disease impact on survival than the additive model.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Cancer Clinical Trials

Background:

  • Patient survival is a key metric in cancer clinical trials.
  • Relative survival rate adjusts for non-disease mortality.
  • Existing models may not fully capture disease-specific mortality patterns.

Purpose of the Study:

  • To develop and evaluate transformation models for cause-specific hazard rates.
  • To assess the impact of clinical trial interventions on population survival.
  • To determine the most appropriate model structure (additive vs. multiplicative) for survival data.

Main Methods:

  • Incorporated an additive hazards model for overall mortality.
  • Considered transformation models for cause-specific hazard rates.

Related Experiment Videos

  • Utilized generalized linear models for fitting and applied to Hodgkin's disease data.

    • Main Results:

    • Developed a method for estimating transformation parameters.
    • Demonstrated the flexibility of the generalized linear model framework.
    • Found the multiplicative structure to be a more appropriate fit for the Hodgkin's disease data.

    Conclusions:

    • Transformation models offer a flexible approach to analyzing disease processes in survival data.
    • The multiplicative model provides a better fit than the additive model for the studied Hodgkin's disease data.
    • Statistical software facilitates the application of these advanced survival models.